Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Technetium Tc 99m sulfur colloid injection - Pharmalucence

Next Previous
Drug Profile

Technetium Tc 99m sulfur colloid injection - Pharmalucence

Alternative Names: AN-Sulfur Colloid - Pharmalucence; Kit for the preparation of Technetium Tc 99m sulfur colloid injection (SCI) - Pharmalucence; Tc 99m sulfur colloid kit

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharmalucence
  • Class Imaging agents; Inorganic sulfur compounds; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malignant melanoma
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer; Malignant melanoma

Most Recent Events

  • 16 Aug 2012 Launched for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Registered for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Technetium Tc 99m sulfur colloid injection - Pharmalucence receives Orphan Drug status for Malignant melanoma (localisation of lymph nodes) in USA
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top